Skip to Main Content (Press Enter)

Logo UNINSUBRIA
  • ×
  • Home
  • Corsi
  • Insegnamenti
  • Professioni
  • Persone
  • Pubblicazioni
  • Strutture
  • Terza Missione
  • Attività
  • Competenze
  • Attrezzature

UNI-FIND
Logo UNINSUBRIA

|

UNI-FIND

uninsubria.it
  • ×
  • Home
  • Corsi
  • Insegnamenti
  • Professioni
  • Persone
  • Pubblicazioni
  • Strutture
  • Terza Missione
  • Attività
  • Competenze
  • Attrezzature
  1. Pubblicazioni

Potential gender differences of exenatide in outpatients with type 2 diabetes mellitus

Articolo
Data di Pubblicazione:
2015
Abstract:
Objectives: Exenatide, a glucagon-like peptide 1 (GLP-1) receptor agonist, reduces glycated hemoglobin (A1C) and body weight (BW) and improves cardiovascular (CV) risk factors in some but not all patients. This study was planned to evaluate a potential gender difference of exenatide’s effects in diabetic subjects. Study Design: A retrospective study comparing metabolic control and changes in weight, waist circumference, and body mass index according to gender. Methods: We retrospectively collected clinical data from 69 outpatients with type 2 diabetes mellitus (34 male and 35 female), mean age = 52.6 years (SD = 10.3); mean duration of diabetes = 9.4 years (SD = 5.4) with persistent exenatide treatment, evaluating the evolution of anthropometric, clinical, and metabolic parameters. Results: Exenatide rapidly reduced A1C, fasting plasma glucose (FPG), BW, and waist circumference (WC) in both genders (all P values <.0001). WC was more reduced in women after 12 months of treatment (P =.02). After 24 months, patients showed a stable reduction of A1C and FPG (all P values <.0001 vs baseline) without any gender-related difference, while BW lowering was more pronounced in women compared with men (P =.002). Conclusions: Exenatide effected a sustained improvement in metabolic and anthropometric parameters in both genders, but BW and WC were more reduced in females. The women with diabetes experienced a more prominent therapeutic benefit for some CV risk factors and a reduction in waist circumference and body weight.
Tipologia CRIS:
Articolo su Rivista
Elenco autori:
Bossi, A. C.; Pulcina, A.; Ansah, E. O.; Balini, A.; Berzi, D.; Meregalli, G.; Veronesi, Giovanni
Autori di Ateneo:
VERONESI GIOVANNI
Link alla scheda completa:
https://irinsubria.uninsubria.it/handle/11383/2030891
Pubblicato in:
THE AMERICAN JOURNAL OF PHARMACY BENEFITS
Journal
  • Dati Generali

Dati Generali

URL

http://www.scopus.com/inward/record.url?eid=2-s2.0-84943195931&partnerID=40&md5=ab0b7c396cdb8e4ecb6b326b11b04ab9
  • Accessibilità
  • Utilizzo dei cookie

Realizzato con VIVO | Designed by Cineca | 26.10.1.0